APO Research
Talk to an analyst

APO RESEARCH · REPORT

Teriflunomide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Teriflunomide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025193 pages

Choose your research edition.

Industry ResearchTeriflunomide Tablets Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Teriflunomide Tablets Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Teriflunomide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Teriflunomide Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Teriflunomide Tablets Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Teriflunomide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Teriflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Teriflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Teriflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Teriflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Teriflunomide Tablets include Teva, CGeneTech (Suzhou, China), Nanjing Healthnice Pharmaceutical, Mylan, Cisen Pharmaceutical, Zydus, Viatris, SOLA Pharmaceuticals and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Teriflunomide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Teriflunomide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Teriflunomide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Teriflunomide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Teriflunomide Tablets Segment by Company

Teva

CGeneTech (Suzhou, China)

Nanjing Healthnice Pharmaceutical

Mylan

Cisen Pharmaceutical

Zydus

Viatris

SOLA Pharmaceuticals

Sanofi

Sandoz

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Camber Pharmaceuticals

Aurobindo Pharma

Apotex

Alembic

Accord Healthcare

Teriflunomide Tablets Segment by Type

7mg per Tablet

14mg per Tablet

Teriflunomide Tablets Segment by Application

Hospital and Clinic

Pharmacy

Other

Teriflunomide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriflunomide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Teriflunomide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriflunomide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Teriflunomide Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Teriflunomide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Teriflunomide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Teriflunomide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Teriflunomide Tablets Industry Trends Table 2. Teriflunomide Tablets Industry Drivers Table 3. Teriflunomide Tablets Industry Opportunities and Challenges Table 4. Teriflunomide Tablets Industry Restraints Table 5. Global Teriflunomide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Teriflunomide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Teriflunomide Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Teriflunomide Tablets Sales Market Share by Manufacturers Table 9. Global Teriflunomide Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Teriflunomide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Teriflunomide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Teriflunomide Tablets Manufacturers, Product Type & Application Table 13. Global Teriflunomide Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Teriflunomide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 7mg per Tablet Table 17. Major Manufacturers of 14mg per Tablet Table 18. Global Teriflunomide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Teriflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Teriflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Teriflunomide Tablets Sales Market Share by Type (2021-2026) Table 22. Global Teriflunomide Tablets Sales Market Share by Type (2027-2032) Table 23. Global Teriflunomide Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Teriflunomide Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Teriflunomide Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Teriflunomide Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Teriflunomide Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Pharmacy Table 30. Major Manufacturers of Other Table 31. Global Teriflunomide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Teriflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Teriflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Teriflunomide Tablets Sales Market Share by Application (2021-2026) Table 35. Global Teriflunomide Tablets Sales Market Share by Application (2027-2032) Table 36. Global Teriflunomide Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Teriflunomide Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Teriflunomide Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Teriflunomide Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Teriflunomide Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Teriflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Teriflunomide Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Teriflunomide Tablets Sales Market Share by Region (2021-2026) Table 44. Global Teriflunomide Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Teriflunomide Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Teriflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Teriflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Teriflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Teriflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Teriflunomide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Teriflunomide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Teriflunomide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Teriflunomide Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Teriflunomide Tablets Revenue Market Share by Region (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Teva Teriflunomide Tablets Product Portfolio Table 67. Teva Recent Development Table 68. CGeneTech (Suzhou, China) Company Information Table 69. CGeneTech (Suzhou, China) Business Overview Table 70. CGeneTech (Suzhou, China) Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CGeneTech (Suzhou, China) Teriflunomide Tablets Product Portfolio Table 72. CGeneTech (Suzhou, China) Recent Development Table 73. Nanjing Healthnice Pharmaceutical Company Information Table 74. Nanjing Healthnice Pharmaceutical Business Overview Table 75. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product Portfolio Table 77. Nanjing Healthnice Pharmaceutical Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mylan Teriflunomide Tablets Product Portfolio Table 82. Mylan Recent Development Table 83. Cisen Pharmaceutical Company Information Table 84. Cisen Pharmaceutical Business Overview Table 85. Cisen Pharmaceutical Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Cisen Pharmaceutical Teriflunomide Tablets Product Portfolio Table 87. Cisen Pharmaceutical Recent Development Table 88. Zydus Company Information Table 89. Zydus Business Overview Table 90. Zydus Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Zydus Teriflunomide Tablets Product Portfolio Table 92. Zydus Recent Development Table 93. Viatris Company Information Table 94. Viatris Business Overview Table 95. Viatris Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Viatris Teriflunomide Tablets Product Portfolio Table 97. Viatris Recent Development Table 98. SOLA Pharmaceuticals Company Information Table 99. SOLA Pharmaceuticals Business Overview Table 100. SOLA Pharmaceuticals Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. SOLA Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 102. SOLA Pharmaceuticals Recent Development Table 103. Sanofi Company Information Table 104. Sanofi Business Overview Table 105. Sanofi Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sanofi Teriflunomide Tablets Product Portfolio Table 107. Sanofi Recent Development Table 108. Sandoz Company Information Table 109. Sandoz Business Overview Table 110. Sandoz Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sandoz Teriflunomide Tablets Product Portfolio Table 112. Sandoz Recent Development Table 113. Glenmark Pharmaceuticals Company Information Table 114. Glenmark Pharmaceuticals Business Overview Table 115. Glenmark Pharmaceuticals Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Glenmark Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 117. Glenmark Pharmaceuticals Recent Development Table 118. Dr. Reddy's Laboratories Company Information Table 119. Dr. Reddy's Laboratories Business Overview Table 120. Dr. Reddy's Laboratories Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Dr. Reddy's Laboratories Teriflunomide Tablets Product Portfolio Table 122. Dr. Reddy's Laboratories Recent Development Table 123. Camber Pharmaceuticals Company Information Table 124. Camber Pharmaceuticals Business Overview Table 125. Camber Pharmaceuticals Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Camber Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 127. Camber Pharmaceuticals Recent Development Table 128. Aurobindo Pharma Company Information Table 129. Aurobindo Pharma Business Overview Table 130. Aurobindo Pharma Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Aurobindo Pharma Teriflunomide Tablets Product Portfolio Table 132. Aurobindo Pharma Recent Development Table 133. Apotex Company Information Table 134. Apotex Business Overview Table 135. Apotex Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Apotex Teriflunomide Tablets Product Portfolio Table 137. Apotex Recent Development Table 138. Alembic Company Information Table 139. Alembic Business Overview Table 140. Alembic Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Alembic Teriflunomide Tablets Product Portfolio Table 142. Alembic Recent Development Table 143. Accord Healthcare Company Information Table 144. Accord Healthcare Business Overview Table 145. Accord Healthcare Teriflunomide Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Accord Healthcare Teriflunomide Tablets Product Portfolio Table 147. Accord Healthcare Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Teriflunomide Tablets Distributors List Table 151. Teriflunomide Tablets Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Teriflunomide Tablets Product Image Figure 2. Global Teriflunomide Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Teriflunomide Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Teriflunomide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Teriflunomide Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Teriflunomide Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 7mg per Tablet Image Figure 9. 14mg per Tablet Image Figure 10. Global Teriflunomide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Teriflunomide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Teriflunomide Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Teriflunomide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Teriflunomide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Teriflunomide Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Pharmacy Image Figure 18. Other Image Figure 19. Global Teriflunomide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Teriflunomide Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Teriflunomide Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Teriflunomide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Teriflunomide Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Teriflunomide Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Teriflunomide Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Teriflunomide Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Teriflunomide Tablets Sales Market Share by Country (2021-2032) Figure 39. China Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Teriflunomide Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Teriflunomide Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Teriflunomide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Teriflunomide Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Teriflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Teriflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Teriflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Teriflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Teriflunomide Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Teriflunomide Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 7mg per Tablet
  • 14mg per Tablet
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Teva
  • CGeneTech (Suzhou, China)
  • Nanjing Healthnice Pharmaceutical
  • Mylan
  • Cisen Pharmaceutical
  • Zydus
  • Viatris
  • SOLA Pharmaceuticals
  • Sanofi
  • Sandoz
  • Glenmark Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Camber Pharmaceuticals
  • Aurobindo Pharma
  • Apotex
  • Alembic
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Teriflunomide Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Teriflunomide Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Teriflunomide Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Teriflunomide Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Teriflunomide Tablets Market Dynamics
  1. 2.1 Teriflunomide Tablets Industry Trends
  2. 2.2 Teriflunomide Tablets Industry Drivers
  3. 2.3 Teriflunomide Tablets Industry Opportunities and Challenges
  4. 2.4 Teriflunomide Tablets Industry Restraints
3 Teriflunomide Tablets Market by Manufacturers
  1. 3.1 Global Teriflunomide Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Teriflunomide Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Teriflunomide Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Teriflunomide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Teriflunomide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Teriflunomide Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Teriflunomide Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Teriflunomide Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Teriflunomide Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Teriflunomide Tablets Tier 1, Tier 2, and Tier 3
4 Teriflunomide Tablets Market by Type
  1. 4.1 Teriflunomide Tablets Type Introduction
  2. 4.1.1 7mg per Tablet
  3. 4.1.2 14mg per Tablet
  4. 4.2 Global Teriflunomide Tablets Sales by Type
  5. 4.2.1 Global Teriflunomide Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Teriflunomide Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Teriflunomide Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Teriflunomide Tablets Revenue by Type
  9. 4.3.1 Global Teriflunomide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Teriflunomide Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Teriflunomide Tablets Revenue Market Share by Type (2021-2032)
5 Teriflunomide Tablets Market by Application
  1. 5.1 Teriflunomide Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Teriflunomide Tablets Sales by Application
  6. 5.2.1 Global Teriflunomide Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Teriflunomide Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Teriflunomide Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Teriflunomide Tablets Revenue by Application
  10. 5.3.1 Global Teriflunomide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Teriflunomide Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Teriflunomide Tablets Revenue Market Share by Application (2021-2032)
6 Global Teriflunomide Tablets Sales by Region
  1. 6.1 Global Teriflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Teriflunomide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Teriflunomide Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Teriflunomide Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Teriflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Teriflunomide Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Teriflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Teriflunomide Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Teriflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Teriflunomide Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Teriflunomide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Teriflunomide Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Teriflunomide Tablets Revenue by Region
  1. 7.1 Global Teriflunomide Tablets Revenue by Region
  2. 7.1.1 Global Teriflunomide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Teriflunomide Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Teriflunomide Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Teriflunomide Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Teriflunomide Tablets Revenue (2021-2032)
  8. 7.2.2 North America Teriflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Teriflunomide Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Teriflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Teriflunomide Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Teriflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Teriflunomide Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Teriflunomide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Teriflunomide Tablets Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 CGeneTech (Suzhou, China)
  8. 8.2.1 CGeneTech (Suzhou, China) Company Information
  9. 8.2.2 CGeneTech (Suzhou, China) Business Overview
  10. 8.2.3 CGeneTech (Suzhou, China) Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CGeneTech (Suzhou, China) Teriflunomide Tablets Product Portfolio
  12. 8.2.5 CGeneTech (Suzhou, China) Recent Developments
  13. 8.3 Nanjing Healthnice Pharmaceutical
  14. 8.3.1 Nanjing Healthnice Pharmaceutical Company Information
  15. 8.3.2 Nanjing Healthnice Pharmaceutical Business Overview
  16. 8.3.3 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product Portfolio
  18. 8.3.5 Nanjing Healthnice Pharmaceutical Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Teriflunomide Tablets Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Cisen Pharmaceutical
  26. 8.5.1 Cisen Pharmaceutical Company Information
  27. 8.5.2 Cisen Pharmaceutical Business Overview
  28. 8.5.3 Cisen Pharmaceutical Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cisen Pharmaceutical Teriflunomide Tablets Product Portfolio
  30. 8.5.5 Cisen Pharmaceutical Recent Developments
  31. 8.6 Zydus
  32. 8.6.1 Zydus Company Information
  33. 8.6.2 Zydus Business Overview
  34. 8.6.3 Zydus Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Teriflunomide Tablets Product Portfolio
  36. 8.6.5 Zydus Recent Developments
  37. 8.7 Viatris
  38. 8.7.1 Viatris Company Information
  39. 8.7.2 Viatris Business Overview
  40. 8.7.3 Viatris Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Teriflunomide Tablets Product Portfolio
  42. 8.7.5 Viatris Recent Developments
  43. 8.8 SOLA Pharmaceuticals
  44. 8.8.1 SOLA Pharmaceuticals Company Information
  45. 8.8.2 SOLA Pharmaceuticals Business Overview
  46. 8.8.3 SOLA Pharmaceuticals Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SOLA Pharmaceuticals Teriflunomide Tablets Product Portfolio
  48. 8.8.5 SOLA Pharmaceuticals Recent Developments
  49. 8.9 Sanofi
  50. 8.9.1 Sanofi Company Information
  51. 8.9.2 Sanofi Business Overview
  52. 8.9.3 Sanofi Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi Teriflunomide Tablets Product Portfolio
  54. 8.9.5 Sanofi Recent Developments
  55. 8.10 Sandoz
  56. 8.10.1 Sandoz Company Information
  57. 8.10.2 Sandoz Business Overview
  58. 8.10.3 Sandoz Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sandoz Teriflunomide Tablets Product Portfolio
  60. 8.10.5 Sandoz Recent Developments
  61. 8.11 Glenmark Pharmaceuticals
  62. 8.11.1 Glenmark Pharmaceuticals Company Information
  63. 8.11.2 Glenmark Pharmaceuticals Business Overview
  64. 8.11.3 Glenmark Pharmaceuticals Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Glenmark Pharmaceuticals Teriflunomide Tablets Product Portfolio
  66. 8.11.5 Glenmark Pharmaceuticals Recent Developments
  67. 8.12 Dr. Reddy's Laboratories
  68. 8.12.1 Dr. Reddy's Laboratories Company Information
  69. 8.12.2 Dr. Reddy's Laboratories Business Overview
  70. 8.12.3 Dr. Reddy's Laboratories Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dr. Reddy's Laboratories Teriflunomide Tablets Product Portfolio
  72. 8.12.5 Dr. Reddy's Laboratories Recent Developments
  73. 8.13 Camber Pharmaceuticals
  74. 8.13.1 Camber Pharmaceuticals Company Information
  75. 8.13.2 Camber Pharmaceuticals Business Overview
  76. 8.13.3 Camber Pharmaceuticals Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Camber Pharmaceuticals Teriflunomide Tablets Product Portfolio
  78. 8.13.5 Camber Pharmaceuticals Recent Developments
  79. 8.14 Aurobindo Pharma
  80. 8.14.1 Aurobindo Pharma Company Information
  81. 8.14.2 Aurobindo Pharma Business Overview
  82. 8.14.3 Aurobindo Pharma Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aurobindo Pharma Teriflunomide Tablets Product Portfolio
  84. 8.14.5 Aurobindo Pharma Recent Developments
  85. 8.15 Apotex
  86. 8.15.1 Apotex Company Information
  87. 8.15.2 Apotex Business Overview
  88. 8.15.3 Apotex Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Apotex Teriflunomide Tablets Product Portfolio
  90. 8.15.5 Apotex Recent Developments
  91. 8.16 Alembic
  92. 8.16.1 Alembic Company Information
  93. 8.16.2 Alembic Business Overview
  94. 8.16.3 Alembic Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Alembic Teriflunomide Tablets Product Portfolio
  96. 8.16.5 Alembic Recent Developments
  97. 8.17 Accord Healthcare
  98. 8.17.1 Accord Healthcare Company Information
  99. 8.17.2 Accord Healthcare Business Overview
  100. 8.17.3 Accord Healthcare Teriflunomide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Accord Healthcare Teriflunomide Tablets Product Portfolio
  102. 8.17.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Teriflunomide Tablets Value Chain Analysis
  2. 9.1.1 Teriflunomide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Teriflunomide Tablets Production Mode & Process
  6. 9.2 Teriflunomide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Teriflunomide Tablets Distributors
  9. 9.2.3 Teriflunomide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst